IRVINE, Calif.--(BUSINESS WIRE)--Khang & Khang LLP (the “Firm”) announces that it is investigating claims against Diplomat Pharmacy, Inc. (“Diplomat Pharmacy” or the “Company”) (NYSE: DPLO) concerning possible violations of federal securities laws.
If you purchased shares of Diplomat Pharmacy and want more information, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at firstname.lastname@example.org.
This investigation focuses on whether Diplomat Pharmacy and certain of its directors and/or officers violated federal securities laws. On November 2, 2016, Diplomat Pharmacy announced third quarter 2016 results that fell below investors’ expectations. The Company also lowered full year 2016 guidance. When this information was disclosed, shares of Diplomat Pharmacy declined in value.
If you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at email@example.com.
This press release may constitute Attorney Advertising in some jurisdictions.